Three new tools launched to accelerate development of medicines in the EU via PRIME
PRIority MEdicines (PRIME) is a scheme run by the EMA to enhance support for the development of medicines targeting unmet medical needs. It is based on early dialogue with companies to optimise development plans and speed up evaluation. EMA has…